Intralesional steroids in cutaneous hemangioma.
Cutaneous hemangiomas are present in 2.6% of all newborn children. Conservative management is the preferred method of treatment, and only cases with a high risk of complications should be treated. Periocular cutaneous hemangiomas have been associated with ophthalmic complications in 41%-100% of such cases. Intralesional steroids are frequently used by ophthalmologists for treatment of periocular hemangiomas. We present a case of cutaneous hemangioma treated with this modality. No previous cases have been reported in the dermatologic literature. A review, description, and complications of the use of intralesional steroids in hemangiomas are included.
Reyes
B A
BA
Department of Dermatology, University of Puerto Rico Medical School, San Juan.
Vazquez-Botet
M
M
Capo
H
H
D000550:Amblyopia / Q000517:prevention & control; D005153:Facial Neoplasms / Q000151:congenital / Q000188:drug therapy*; D005260:Female; D006391:Hemangioma / Q000151:congenital / Q000188:drug therapy*; D006801:Humans; D007231:Infant, Newborn; D012878:Skin Neoplasms / Q000151:congenital / Q000188:drug therapy*; D014222:Triamcinolone Acetonide / Q000627:therapeutic use*
D014222:Triamcinolone Acetonide